http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-26539-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| filingDate | 2001-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fc31954b44d2d006accf51be0e4d63f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcad364f39c006699fa2498f8f74bc70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_810d4622159ea89d8eb3fdef3203c97a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c45ffa31c4ecf892fb2e3cab68504d5 |
| publicationDate | 2001-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UY-26539-A1 |
| titleOfInvention | DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY. |
| abstract | A pharmaceutical composition comprising as a first active ingredient an estrogen, such as estradiol or estradiol valerate, in amounts sufficient to treat disorders and symptoms associated with endogenous estrogen deficient levels in women, and as a second active ingredient 6b, 7b; 15b; 16b-dimethyl-3-oxo-17a-preg-4-ene-21, 17-carbolactone (drospirenone, DRSP) in sufficient amounts to protect the endometrium from the adverse effects of estrogen. |
| priorityDate | 2001-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.